BLUE - bluebird bio, Inc.
4.97
0 0%
Share volume: 1,245,197
Last Updated: 05-30-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$4.97
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 09-13-2024 | 09-27-2024 | 11-14-2024 | 03-27-2025 | 05-14-2025 | |
| Assets | ||||||
| Total Assets | 631.483 M | 545.193 M | 465.056 M | 460.232 M | 295.957 M | |
| Current Assets | 271.601 M | 203.516 M | 150.811 M | 154.668 M | 174.524 M | |
| Inventories | 30.305 M | 33.330 M | 53.944 M | 65.017 M | 83.283 M | |
| Other Current Assets | 17.738 M | 15.580 M | 18.663 M | 16.712 M | 4.060 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 212.047 M | 144.067 M | 70.651 M | 62.305 M | 78.744 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 90.366 M | 78.756 M | 62.593 M | 60.848 M | 60.405 M | |
| Other Assets | 269.516 M | 262.921 M | 251.652 M | 244.716 M | 61.028 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 631.483 M | 545.193 M | 465.056 M | 460.232 M | 295.957 M | |
| Total liabilities | 500.437 M | 492.212 M | 470.842 M | 491.766 M | 353.823 M | |
| Total current liabilities | 293.573 M | 297.930 M | 296.032 M | 321.462 M | 315.078 M | |
| Accounts Payable | 19.387 M | 30.591 M | 24.481 M | 34.316 M | 42.624 M | |
| Other liabilities | 180.775 M | 174.627 M | 169.135 M | 162.508 M | 23.663 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 180.775 M | 174.627 M | 169.135 M | 162.508 M | 23.663 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 131.046 M | 52.981 M | -5.786 M | -31.534 M | -57.866 M | |
| Common stock | 4.463 B | 4.467 B | 4.468 B | 4.472 B | 4.474 B | |
| Retained earnings | -4.330 B | -4.412 B | -4.472 B | -4.501 B | -4.530 B |